(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

FORMULAÇÕES DE ANTICORPO ANTI-SIGLEC-8

ArquivadaInvention PatentPCT · US2021071958

Application data

Number

112023007428

Type

Invention Patent

Filing

10/21/2021

Publication

06/27/2023

PCT

US2021071958

Progress at the INPI

  1. Filing10/21/21
  2. Publication06/27/23
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 10/21/2021 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 01/14/2025. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

ALLAKOS INC.

US

See this company's full portfolio

Inventors

D. Y. (pessoa física)

US

R. C. (pessoa física)

US

Technical data

Priority claims

US

63/104,436 · 10/22/2020

Abstract

FORMULAÇÕES DE ANTICORPO ANTISIGLEC-8. A presente invenção refere-se a composições farmacêuticas (por exemplo, formulações líquidas) compreendendo um anticorpo monoclonal que se liga a um Siglec-8 humano para administração subcutânea, bem como artigos de fabricação relacionados ao mesmo.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

01/14/2025

RPI 2819

Arquivamento - Art. 33 da LPI

#11.1

10/29/2024

RPI 2808

Notificação de entrada na fase nacional - PCT

#1.3

06/27/2023

RPI 2738

Alteração de dados cadastrais

#1.1

05/02/2023

RPI 2730

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.